Global Vision

Healthy Ageing
for All.

Ambr Institute is a medical technology organization dedicated to bridging the gap between advanced computational biology and daily clinical practice. We provide physicians with high-resolution insights into biological processes to ensure personalized prevention is accessible to every patient, everywhere in the world.

Evolution

Founding Principles

The institute was established to address a pivotal metamorphosis in global healthcare: the transition from reactive, symptom-based intervention to a proactive prevention model.

Mission

Bridging the Gap between Computation and Care

Medical research often operates in isolation from clinical application. Ambr acts as the synthesis layer, leveraging Explainable AI (XAI) to provide clinicians with the clarity sought by proactive patients while meeting the rigorous evidence-based requirements of the medical community.

Concept

The Digital Twin Protocol

The Ambr platform unifies clinical, lifestyle, and multi-omic data (including genetics, epigenetics, and blood biomarkers) to generate a live virtual model. This twin predicts risk for age-associated chronic diseases, or surgical complications, transforming the patient into a modifiable biological system rather than a collection of symptoms.

Multi-Modal Data Synthesis

Aggregating multiple sources of biomarkers, and real-time lifestyle assessments to établish biological rationale.

Explainable AI (XAI)

Rejecting the "black box" model by pinpointing specific biomarker interactions that drive risk scores.

Prediction ability +94%

For forecasting the developmet of Diabete type II within the next 10 years.

Scientific Goals

Medicine with Rigor

The Ambr Research Institute operates as a competency hub for precision medicine. Every algorithm developed is grounded in peer-reviewed scientific literature to ensure objectivity and ethical responsibility.

Collaboration Network
Karolinska Institute

Developing methods for AI interpretability and transparency.

University of Oslo

Leading clinical trials in digital prehabilitation and surgery.

University of Bergen

Focusing on rare carcinoma detection and stratification.

Univ. of Tampere

Developing methods for AI interpretability and transparency, and models for surgery prediction

Media & Publications

In the Press

Scientific Inquiries & Global Partnerships

[email protected]